Solamargine alleviates liver fibrosis by regulating YAP signaling in hepatic stellate cells.

OBJECTIVES: )-induced mouse model of liver fibrosis. METHODS: . RESULTS: <0.05). CONCLUSIONS: . These findings suggest that solamargine holds promise as a potential antifibrotic therapeutic agent.